On Aug 06, 2026, CVSA reported earnings of 2.09 USD per share (EPS) for Q4 26, beating the estimate of 1.93 USD, resulting in a 8.27% surprise. Revenue reached 501.38 million, compared to an expected 496.36 million, with a 1.01% difference. The market reacted with a +13.46% price change (close before vs. close after earnings).
Looking ahead to Q1 27, -- analysts forecast an EPS of 1.82 USD, with revenue projected to reach 501.32 million USD, implying an decrease of -12.92% EPS, and decrease of -0.01% in Revenue from the last quarter.